Calcium phosphate cement in musculoskeletal tumor surgery

Abstract

CPC appears to offer a useful bone substitute for the treatment of musculoskeletal tumors. As the follow-up period for this study was short, further long-term follow-up studies are needed.

Function After Injection of Benign Bone Lesions with a Bioceramic

“…4). This is in contrast to patients treated with pure CaPO 4 bone graft substitutes in whom residual graft material can be seen for years postoperatively and possibly permanently [21,24].…”

“…Each author certifies that his or her institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained. [16,21,32] and osteoconductive [16,21,32]. Furthermore, they do not contain potent cytokines [16,21,32], which may be contraindicated in the presence of tumors.…”

“…[16,21,32] and osteoconductive [16,21,32]. Furthermore, they do not contain potent cytokines [16,21,32], which may be contraindicated in the presence of tumors. In a selective review, Rougraff documented the limited published data on the use of bone graft substitutes in orthopaedic oncology [24].…”

“…In a selective review, Rougraff documented the limited published data on the use of bone graft substitutes in orthopaedic oncology [24]. Most reported series using surgical-grade CaSO 4 [16,17,20,22] or CaPO 4 [21] graft materials to treat patients with benign bone tumors are relatively small with short followup. While various bone graft substitutes may be used to treat bone lesions, common complications still exist [16,17,20,21,24].…”

“…Most reported series using surgical-grade CaSO 4 [16,17,20,22] or CaPO 4 [21] graft materials to treat patients with benign bone tumors are relatively small with short followup. While various bone graft substitutes may be used to treat bone lesions, common complications still exist [16,17,20,21,24]. One of the major factors in determining the quality of bone graft substitutes is the rate of graft incorporation into the host bone.…”